Mastering the Beating Heart: Mitral Valve Disease
Mitral valve disease is a condition that affects the mitral valve, causing blood to leak backward or flow too slowly, and can ...
FDA approves early feasibility study of Valcare’s transcatheter device
The US Food and Drug Administration (FDA) has granted approval for Valcare Medical’s investigational device exemption ...
News-Medical.Net on MSN7h
Study explores impact of severe tricuspid regurgitation in AFMR patients
Atrial functional mitral regurgitation (AFMR) is a common type of MR linked to high rates of heart failure, highlighting the ...
EurekAlert!8h
A closer look at severe tricuspid regurgitation in AFMR patients
Tricuspid regurgitation (TR) is common in patients with atrial functional mitral regurgitation (AFMR) but its impact is not ...
Valcare Medical Receives FDA Approval to Initiate Early Feasibility Study for its Novel AMEND™ Trans-Septal System
Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the U.S. Food and Drug ...
MedTech Dive2d
Capstan brings surgical robot to valve replacement
Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...
How Yale doctors used a balloon in surgery to treat heart issue
Yale operates first the BATMAN procedure in CT, a less invasive heart treatment offering faster recovery and new hope for ...
Fierce Biotech6d
Boston Scientific backs mitral valve developer 4C Medical in $175M round
Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...
EurekAlert!1d
Drivers and impacts of severe tricuspid regurgitation in atrial functional mitral regurgitation cases (IMAGE)
Tricuspid regurgitation (TR) is common in patients with atrial functional mitral regurgitation (AFMR). However, very few studies have explored its clinical characteristics, determinants, and ...
Medindia23h
Valcare Medical Receives FDA Approval to Initiate Early Feasibility Study for its Novel AMEND Trans-Septal System
Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the U.S. Food and Drug Administration (FDA) has approved the AMEND� Trans-Septal System for ...